Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 2465763, 10 pages
http://dx.doi.org/10.1155/2016/2465763
Review Article

Potential Diagnostic and Prognostic Biomarkers of Epigenetic Drift within the Cardiovascular Compartment

1School of Health & Human Performance, Dublin City University, Ireland
2INSERM 1083, Angers Medical University, France
3School of Biotechnology, Dublin City University, Ireland
4The Biodesign Institute, School of Life Sciences, Arizona State University, USA

Received 24 July 2015; Revised 2 November 2015; Accepted 24 November 2015

Academic Editor: Xia Li

Copyright © 2016 Robert G. Wallace et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. J. Hunt, N. L. Baker, P. A. Cleary, R. Klein, G. Virella, and M. F. Lopes-Virella, “Longitudinal association between endothelial dysfunction, inflammation, and clotting biomarkers with subclinical atherosclerosis in type 1 diabetes: an evaluation of the DCCT/EDIC cohort,” Diabetes Care, vol. 38, no. 7, pp. 1281–1289, 2015. View at Publisher · View at Google Scholar
  2. J. D. Fontes, J. F. Yamamoto, M. G. Larson et al., “Clinical correlates of change in inflammatory biomarkers: the Framingham Heart Study,” Atherosclerosis, vol. 228, no. 1, pp. 217–223, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Hopkins, G. Stratton, N. D. Ridgers, L. E. F. Graves, N. T. Cable, and D. J. Green, “Lack of relationship between sedentary behaviour and vascular function in children,” European Journal of Applied Physiology, vol. 112, no. 2, pp. 617–622, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. D. A. Bottino, F. G. Lopes, F. J. de Oliveira, A. D. Mecenas, R. Clapauch, and E. Bouskela, “Relationship between biomarkers of inflammation, oxidative stress and endothelial/microcirculatory function in successful aging versus healthy youth: a transversal study,” BMC Geriatrics, vol. 15, article 41, 2015. View at Publisher · View at Google Scholar
  5. M. Mohiuddin, H.-A. Pan, Y.-C. Hung, and G. S. Huang, “Control of growth and inflammatory response of macrophages and foam cells with nanotopography,” Nanoscale Research Letters, vol. 7, no. 1, article 394, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Lugrin, N. Rosenblatt-Velin, R. Parapanov, and L. Liaudet, “The role of oxidative stress during inflammatory processes,” Biological Chemistry, vol. 395, no. 2, pp. 203–230, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. R. C. Marchiori, L. A. F. Pereira, A. A. Naujorks et al., “Improvement of blood inflammatory marker levels in patients with hypothyroidism under levothyroxine treatment,” BMC Endocrine Disorders, vol. 15, article 32, 2015. View at Publisher · View at Google Scholar
  8. R. Casas, E. Sacanella, M. Urpí-Sardà et al., “The effects of the Mediterranean diet on biomarkers of vascular wall inflammation and plaque vulnerability in subjects with high risk for cardiovascular disease. A randomized trial,” PLoS ONE, vol. 9, no. 6, Article ID e100084, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. E. White, “Measurement error in biomarkers: sources, assessment, and impact on studies,” IARC Scientific Publications, no. 163, pp. 143–161, 2011. View at Google Scholar
  10. D. J. West, M. D. Campbell, J. T. Gonzalez et al., “The inflammation, vascular repair and injury responses to exercise in fit males with and without Type 1 diabetes: an observational study,” Cardiovascular Diabetology, vol. 14, article 71, 2015. View at Publisher · View at Google Scholar
  11. D. Baumeister, R. Akhtar, S. Ciufolini, C. M. Pariante, and V. Mondelli, “Childhood trauma and adulthood inflammation: a meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-α,” Molecular Psychiatry, 2015. View at Publisher · View at Google Scholar
  12. H. Cung, M. J. Aragon, K. Zychowski et al., “Characterization of a novel endothelial biosensor assay reveals increased cumulative serum inflammatory potential in stabilized coronary artery disease patients,” Journal of Translational Medicine, vol. 13, no. 1, article 99, 2015. View at Publisher · View at Google Scholar
  13. A. F. Carlin, P. Aristizabal, Q. Song et al., “Temporal dynamics of inflammatory cytokines/chemokines during sofosbuvir and ribavirin therapy for genotype 2 and 3 hepatitis C infection,” Hepatology, vol. 62, no. 4, pp. 1047–1058, 2015. View at Publisher · View at Google Scholar
  14. M. Bawadekar, M. De Andrea, I. Lo Cigno et al., “The extracellular IFI16 protein propagates inflammation in endothelial cells via p38 MAPK and NF-κB p65 activation,” Journal of Interferon & Cytokine Research, vol. 35, no. 6, pp. 441–453, 2015. View at Publisher · View at Google Scholar
  15. A. Alabdali, L. Al-Ayadhi, and A. El-Ansary, “Association of social and cognitive impairment and biomarkers in autism spectrum disorders,” Journal of Neuroinflammation, vol. 11, article 4, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Brindle, A. Beswick, T. Fahey, and S. Ebrahim, “Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review,” Heart, vol. 92, no. 12, pp. 1752–1759, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. J. A. Hernesniemi, I. Seppälä, L.-P. Lyytikäinen et al., “Genetic profiling using genome-wide significant coronary artery disease risk variants does not improve the prediction of subclinical atherosclerosis: the Cardiovascular Risk in Young Finns Study, the Bogalusa Heart Study and the Health 2000 Survey—a meta-analysis of three independent studies,” PLoS ONE, vol. 7, no. 1, Article ID e28931, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. S. L. Berger, T. Kouzarides, R. Shiekhattar, and A. Shilatifard, “An operational definition of epigenetics,” Genes and Development, vol. 23, no. 7, pp. 781–783, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. G. Riddihough and L. M. Zahn, “What is epigenetics?” Science, vol. 330, no. 6004, p. 611, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Udali, P. Guarini, S. Moruzzi, S.-W. Choi, and S. Friso, “Cardiovascular epigenetics: from DNA methylation to microRNAs,” Molecular Aspects of Medicine, vol. 34, no. 4, pp. 883–901, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. P. A. Jones, “Functions of DNA methylation: islands, start sites, gene bodies and beyond,” Nature Reviews Genetics, vol. 13, no. 7, pp. 484–492, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. P. A. Jones, “The DNA methylation paradox,” Trends in Genetics, vol. 15, no. 1, pp. 34–37, 1999. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Yuan, Y. Jiao, S. de Jong et al., “An integrative multi-scale analysis of the dynamic DNA methylation landscape in aging,” PLoS Genetics, vol. 11, no. 2, Article ID e1004996, 2015. View at Publisher · View at Google Scholar
  24. K. Day, L. L. Waite, A. Thalacker-Mercer et al., “Differential DNA methylation with age displays both common and dynamic features across human tissues that are influenced by CpG landscape,” Genome Biology, vol. 14, no. 9, article R102, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Valencia-Morales Mdel, S. Zaina, H. Heyn et al., “The DNA methylation drift of the atherosclerotic aorta increases with lesion progression,” BMC Medical Genomics, vol. 8, article 7, 2015. View at Publisher · View at Google Scholar
  26. R. E. Marioni, S. Shah, A. F. McRae et al., “DNA methylation age of blood predicts all-cause mortality in later life,” Genome Biology, vol. 16, article 25, 2015. View at Publisher · View at Google Scholar
  27. N. T. Jenkins, J. S. Martin, M. H. Laughlin, and J. Padilla, “Exercise-induced signals for vascular endothelial adaptations: implications for cardiovascular disease,” Current Cardiovascular Risk Reports, vol. 6, no. 4, pp. 331–346, 2012. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Mora, N. Cook, J. E. Buring, P. M. Ridker, and I.-M. Lee, “Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms,” Circulation, vol. 116, no. 19, pp. 2110–2118, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Egan, P. L. O’Connor, J. R. Zierath, and D. J. O’Gorman, “Time course analysis reveals gene-specific transcript and protein kinetics of adaptation to short-term aerobic exercise training in human skeletal muscle,” PLoS ONE, vol. 8, no. 9, Article ID e74098, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Rönn, P. Volkov, C. Davegårdh et al., “A six months exercise intervention influences the genome-wide DNA methylation pattern in human adipose tissue,” PLoS Genetics, vol. 9, no. 6, Article ID e1003572, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Horvath, W. Erhart, M. Brosch et al., “Obesity accelerates epigenetic aging of human liver,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 43, pp. 15538–15543, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Rönn, P. Volkov, L. Gillberg et al., “Impact of age, BMI and HbA1c levels on the genome-wide DNA methylation and mRNA expression patterns in human adipose tissue and identification of epigenetic biomarkers in blood,” Human Molecular Genetics, vol. 24, no. 13, pp. 3792–3813, 2015. View at Publisher · View at Google Scholar
  33. L. Gabel, N. D. Ridgers, P. A. Della Gatta et al., “Associations of sedentary time patterns and TV viewing time with inflammatory and endothelial function biomarkers in children,” Pediatric Obesity, 2015. View at Publisher · View at Google Scholar
  34. V. Friand, G. David, and P. Zimmermann, “Syntenin and syndecan in the biogenesis of exosomes,” Biology of the Cell, vol. 107, no. 10, pp. 331–341, 2015. View at Publisher · View at Google Scholar
  35. M. Simons and G. Raposo, “Exosomes—vesicular carriers for intercellular communication,” Current Opinion in Cell Biology, vol. 21, no. 4, pp. 575–581, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Burger, S. Schock, C. S. Thompson, A. C. Montezano, A. M. Hakim, and R. M. Touyz, “Microparticles: biomarkers and beyond,” Clinical Science, vol. 124, no. 7, pp. 423–441, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Ren, J. Yang, R. Xie et al., “Exosomal-like vesicles with immune-modulatory features are present in human plasma and can induce CD4+ T-cell apoptosis in vitro,” Transfusion, vol. 51, no. 5, pp. 1002–1011, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Takahashi, S. Kobayashi, N. Fujino et al., “Differences in the released endothelial microparticle subtypes between human pulmonary microvascular endothelial cells and aortic endothelial cells in vitro,” Experimental Lung Research, vol. 39, no. 4-5, pp. 155–161, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Jung, P. Sörensson, N. Saleh, H. Arheden, L. Rydén, and J. Pernow, “Circulating endothelial and platelet derived microparticles reflect the size of myocardium at risk in patients with ST-elevation myocardial infarction,” Atherosclerosis, vol. 221, no. 1, pp. 226–231, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Garnacho-Montero, M. J. Huici-Moreno, A. Gutiérrez-Pizarraya et al., “Prognostic and diagnostic value of eosinopenia, C-reactive protein, procalcitonin, and circulating cell-free DNA in critically ill patients admitted with suspicion of sepsis,” Critical Care, vol. 18, no. 3, article R116, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Zomer, T. Vendrig, E. S. Hopmans, M. van Eijndhoven, J. M. Middeldorp, and D. M. Pegtel, “Exosomes: fit to deliver small RNA,” Communicative & Integrative Biology, vol. 3, no. 5, pp. 447–450, 2010. View at Google Scholar
  42. P. K. Juvvuna, P. Khandelia, L. M. Lee, and E. V. Makeyev, “Argonaute identity defines the length of mature mammalian microRNAs,” Nucleic Acids Research, vol. 40, no. 14, pp. 6808–6820, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. M. S. Jamaluddin, S. M. Weakley, L. Zhang et al., “miRNAs: roles and clinical applications in vascular disease,” Expert Review of Molecular Diagnostics, vol. 11, no. 1, pp. 79–89, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. M. S. Ebert and P. A. Sharp, “Roles for microRNAs in conferring robustness to biological processes,” Cell, vol. 149, no. 3, pp. 515–524, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Zhu, T. Chen, L. Yang et al., “Regulation of microRNA-155 in atherosclerotic inflammatory responses by targeting MAP3K10,” PLoS ONE, vol. 7, no. 11, Article ID e46551, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. L. M. Simon, L. C. Edelstein, S. Nagalla et al., “Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics,” Blood, vol. 123, no. 16, pp. e37–e45, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. P. Willeit, A. Zampetaki, K. Dudek et al., “Circulating microRNAs as novel biomarkers for platelet activation,” Circulation Research, vol. 112, no. 4, pp. 595–600, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. P. Ferroni, S. Riondino, N. Vazzana, N. Santoro, F. Guadagni, and G. Davì, “Biomarkers of platelet activation in acute coronary syndromes,” Thrombosis and Haemostasis, vol. 108, no. 6, pp. 1109–1123, 2012. View at Publisher · View at Google Scholar
  49. P. Landry, I. Plante, D. L. Ouellet, M. P. Perron, G. Rousseau, and P. Provost, “Existence of a microRNA pathway in anucleate platelets,” Nature Structural & Molecular Biology, vol. 16, no. 9, pp. 961–966, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. B. Laffont, A. Corduan, H. Plé et al., “Activated platelets can deliver mRNA regulatory Ago2microRNA complexes to endothelial cells via microparticles,” Blood, vol. 122, no. 2, pp. 253–261, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. O. Gidlöf, M. van der Brug, J. Ohman et al., “Platelets activated during myocardial infarction release functional miRNA, which can be taken up by endothelial cells and regulate ICAM1 expression,” Blood, vol. 121, no. 19, pp. 3908–3917, 2013. View at Publisher · View at Google Scholar · View at Scopus
  52. Y. Pan, H. Liang, H. Liu et al., “Platelet-secreted microRNA-223 promotes endothelial cell apoptosis induced by advanced glycation end products via targeting the insulin-like growth factor 1 receptor,” Journal of Immunology, vol. 192, no. 1, pp. 437–446, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. D. D. McManus and J. E. Freedman, “MicroRNAs in platelet function and cardiovascular disease,” Nature Reviews Cardiology, vol. 12, no. 12, pp. 711–717, 2015. View at Publisher · View at Google Scholar
  54. J. A. Ward, N. Esa, R. Pidikiti et al., “Circulating cell and plasma microRNA profiles differ between Non-ST-segment and ST-segment-elevation myocardial infarction,” Family Medicine & Medical Science Research, vol. 2, no. 2, article 108, 2013. View at Publisher · View at Google Scholar
  55. A. Kumar and C. P. Cannon, “Acute coronary syndromes: diagnosis and management, part I,” Mayo Clinic Proceedings, vol. 84, no. 10, pp. 917–938, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. B. M. Sondermeijer, A. Bakker, A. Halliani et al., “Platelets in patients with premature coronary artery disease exhibit upregulation of miRNA340 and miRNA624,” PLoS ONE, vol. 6, no. 10, Article ID e25946, 2011. View at Publisher · View at Google Scholar
  57. P. A. Kramer, S. Ravi, B. Chacko, M. S. Johnson, and V. M. Darley-Usmar, “A review of the mitochondrial and glycolytic metabolism in human platelets and leukocytes: implications for their use as bioenergetic biomarkers,” Redox Biology, vol. 2, no. 1, pp. 206–210, 2014. View at Publisher · View at Google Scholar · View at Scopus
  58. P. M. Antony, O. Boyd, C. Trefois et al., “Platelet mitochondrial membrane potential in Parkinson’s disease,” Annals of Clinical and Translational Neurology, vol. 2, no. 1, pp. 67–73, 2015. View at Publisher · View at Google Scholar
  59. S. Zharikov and S. Shiva, “Platelet mitochondrial function: from regulation of thrombosis to biomarker of disease,” Biochemical Society Transactions, vol. 41, no. 1, pp. 118–123, 2013. View at Publisher · View at Google Scholar · View at Scopus
  60. S. M. Jobe, K. M. Wilson, L. Leo et al., “Critical role for the mitochondrial permeability transition pore and cyclophilin D in platelet activation and thrombosis,” Blood, vol. 111, no. 3, pp. 1257–1265, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. A. A. Baccarelli and H.-M. Byun, “Platelet mitochondrial DNA methylation: a potential new marker of cardiovascular disease,” Clinical Epigenetics, vol. 7, no. 1, article 44, 2015. View at Publisher · View at Google Scholar